A Randomized Patient -Blind Controlled Phase III Study to Compare the Efficacy and Safety of Intravenous Ferric Carboxymaltose (Ferinject) With Placebo in Patients With Acute Isovolemic Anemia After Gastrectomy

Trial Profile

A Randomized Patient -Blind Controlled Phase III Study to Compare the Efficacy and Safety of Intravenous Ferric Carboxymaltose (Ferinject) With Placebo in Patients With Acute Isovolemic Anemia After Gastrectomy

Completed
Phase of Trial: Phase III

Latest Information Update: 23 May 2017

At a glance

  • Drugs Ferric carboxymaltose (Primary)
  • Indications Iron deficiency anaemia
  • Focus Therapeutic Use
  • Acronyms FAIRY
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 May 2017 Results published in the JAMA: the Journal of the American Medical Association
    • 19 Oct 2016 Primary endpoint of number of responders has been met, according to results presented at the 24th United European Gastroenterology Week.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top